Compares a hemostatic agent with stitching during ovarian cyst surgery
Tests a bleeding-control agent against stitches in women with endometrioma cysts.
Key facts
- Who runs it
- Seoul National University Hospital
- Where
- Goyang-si and Seoul, South KoreaSee the 2 sites
- Trial code
- Registry title
- Comparison of Hemostatic Agent to Suture in Terms of Hemostatic Function and Preservation of Ovarian Function
- Status
- Recruiting
- People taking part
- 90 people, planned
- Started
- 25 Feb 2021
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Hemostatic agent (EVICEL®) application during laparoscopic ovarian cystectomy
- suturing with barbed sutures during laparoscopic ovarian cystectomy
- Record updated
- 26 June 2023
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women aged 19-45 who are planning keyhole (laparoscopic) surgery to remove ovarian cysts caused by endometriosis. It compares a hemostatic agent with stitches to stop bleeding.
- Age
- 19-45 years
- Sex
- Women only
- Disease stage
- Endometriosis of the ovary (one or both ovaries), diagnosed by ultrasound, with laparoscopic ovarian cystectomy planned. ASA physical status 1 or 2.
- Earlier treatment
- No hormonal therapy within the last 3 months.
- Biomarker or test result
- Regular periods every 21-45 days. Serum Anti-mullerian hormone level must not be lower than 0.05 ng/ml.
Main reasons for not taking part
- Suspected ovarian cancer
- No ovarian endometriosis
- Pregnant or breastfeeding
- Anti-mullerian hormone level lower than 0.05 ng/ml
- Hormonal therapy within the last 3 months
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Informed consent
- Age: 19-45 year-old women
- American Society of Anesthesiologists Physical Status classification 1 or 2
- Plan of laparoscopic ovarian cystectomy for unilateral or bilateral ovarian endometriosis diagnosed by ultrasonography
- Regular menstruation every 21-45 days
Who cannot take part
- Hormonal therapy within recent 3 months
- Suspicious disease of ovarian malignancy
- Lower than 0.05 ng/ml of serum Anti-mullerian hormone level
- Age: 18 and younger, 46 and older
- No 'ovarian' endometriosis
- Pregnancy or breastfeeding
- Considered as inappropriate by the researcher's judgment
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 19 and 45 years old?
Where in South Korea
- Dongguk University Ilsan HospitalGoyang-si, South KoreaContact: Ga Won Yim, MD/PhDNot yet recruiting
- Seoul National University HospitalSeoul, South KoreaContact: Hyunji Lim, MDTaking people
About the trial
What the trial wants to find out
This study aims to evaluate the efficacy of preservation of ovarian function, hemostasis, and safety of a hemostatic agent versus suturing during laparoscopic ovarian cystectomy for ovarian endometriosis.
The 2 groups in the trial
- Hemostatic agent groupTreatment being tested
During laparoscopic ovarian cystectomy, bleeding will be controlled by using a hemostatic agent (EVICEL® Fibrin Sealant, Ethicon, USA), which consist of thrombin and coagulating proteins, mainly fibrinogen and fibronectin. If hemostasis is not fulfilled enough by using it, a additional intervention such as electrocoagulation with bipolar forceps and barbed suture is required to stop bleeding.
Treatment: Hemostatic agent (EVICEL®) application during laparoscopic ovarian cystectomy
- Suturing groupExisting treatment, for comparison
During operation, barbed suture will be applied to the inner surface of ovarian parenchyme where ovarian endometriosis was attached. In this group, if bleeding is continued after suturing, additional electrocoagulation with bipolar forceps will be conducted.
Treatment: suturing with barbed sutures during laparoscopic ovarian cystectomy
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Multi-center, Randomized, Investigator-initiated Trial to Evaluate the Efficacy of PRreservation of ovArian Function, Hemostasis, and sAfety of a Hemostatic Agent Versus Suturing During Laparoscopic Ovarian Cystectomy for Endometrioma
- Plain-language title
- Compares a hemostatic agent with stitching during ovarian cyst surgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT04643106, who can take part
- Publications
- Record updated
- 26 June 2023